Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Ophthalmology
•
Uveitis and Ocular Immunology
How do you decide between steroids alone versus corticosteroids plus csDMARD for non-anterior sarcoid uveitis?
In light of publication from
Jacquot et al in Ophthalmology 2025
Related Questions
How would you approach the management of dry corneal melt in a patient requiring high dose systemic steroids and no apparent underlying systemic autoimmune disease?
How do you approach the management of bilateral non-infectious uveitis in the pediatric population?
What is your algorithm for transitioning a patient with chronic noninfectious posterior uveitis from corticosteroids to immunosuppressive therapy?
When should you consider performing an AC tap in patients with suspected herpetic uveitis?
When would you consider discontinuing immunosuppressive treatment in a quiescent uveitis patient without systemic manifestations of inflammation?
How do you decide between initiating systemic immunotherapy versus local treatment for uveitis with associated HLA-B27 and spondyloarthropathy?
When would you consider using selective laser trabeculoplasty (SLT) for managing uveitic glaucoma?
What is your preferred regimen for treating recalcitrant and recurrent macula-threatening ocular toxoplasmosis?
How would you approach the management of posterior uveitis caused by Toxoplasma gondii in immunocompromised patients, considering the potential for atypical presentations and treatment resistance?
For those using 5% Betadine as a single-use prep, how are you handling the associated costs or aliquoting?